House Bill 447
116th Congress(2019-2020)
Affordable and Safe Prescription Drug Importation Act
Introduced
Introduced in House on Jan 10, 2019
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
447
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No House votes have been held for this bill.
Summary
Affordable and Safe Prescription Drug Importation Act
This bill addresses the importation of drugs from Canada and other foreign countries.
The bill requires the Food and Drug Administration (FDA) to promulgate regulations within 180 days permitting wholesalers, pharmacies, and individuals to import certain prescription drugs from Canada. After two years, The FDA, may permit the importation of prescription drugs from other countries.
The bill establishes a process for certifying foreign sellers—a licensed foreign pharmacy or foreign wholesale distributor.
January 10, 2019
Sort by most recent
01/25/2019
Referred to the Subcommittee on Health.
01/10/2019
Referred to the House Committee on Energy and Commerce.
01/10/2019
Introduced in House
Public Record
Record Updated
Nov 1, 2022 1:49:17 PM